JosephKamelSalamaMD
Radiation Oncology • Durham, NCAssociate Professor, Radiation Oncology, Duke University School of Medicine
Dr. Salama is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2100 Erwin Rd
Durham, NC 27705Phone+1 919-684-8111
Education & Training
University of Chicago/University of Illinois College of Medicine at ChicagoResidency, Radiation Oncology, 2002 - 2006
University of Texas Health Science Center at HoustonInternship, Transitional Year, 2001 - 2002
Baylor College of MedicineClass of 2001
Certifications & Licensure
NC State Medical License 2010 - 2025
IL State Medical License 2002 - 2011- American Board of Radiology Radiation Oncology
Clinical Trials
- Sunitinib, Cetuximab, and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck Start of enrollment: 2008 Jul 01
- Dose Escalation Study of RAD001 in Combination w/Chemotherapy & Radiation in Patients With NSCLC Start of enrollment: 2010 Feb 01
Publications & Presentations
PubMed
- Survival and recurrence rates following SBRT or surgery in medically operable Stage I NSCLC.Michael Snider, Joseph K Salama, Matthew Boyer
Lung Cancer. 2024-11-01 - Determinants of Symptomatic Intracranial Progression After an Initial Stereotactic Radiosurgery Course.Jim X Leng, David J Carpenter, Christina Huang, Jamiluddin Qazi, Muzamil Arshad
Advances in Radiation Oncology. 2024-06-01 - 3 citationsCurrent Strengths and Weaknesses of ChatGPT as a Resource for Radiation Oncology Patients and Providers.Warren Floyd, Troy Kleber, David J Carpenter, Melisa Pasli, Jamiluddin Qazi
International Journal of Radiation Oncology, Biology, Physics. 2024-03-15
Journal Articles
- Classification for Long-Term Survival in Oligometastatic Patients Treated with Ablative Radiotherapy: A Multi-Institutional Pooled AnalysisJulian C Hong, A William Blackstock, Joseph K Salama, Paul Okunieff, Michael T Milano, James J Urbanic, Ralph R Weichselbaum, Johnny Kao, Max W Sung, Steven J Chmura, PLoS One
Other
- Reirradiation for locally recurrent head and neck cancerSalama JK, Haraf DJ, Milano MT
http://www.uptodate.com/contents/reirradiation-for-locally-recurrent-head-and-neck-cancer
UpToDate, Wolters Kluwer Health - 2012-07-20 - Treatment of early (stage I and II) head and neck cancer: The hypopharynxSalama JK, Song S
http://www.uptodate.com/contents/treatment-of-early-stage-i-and-ii-head-and-neck-cancer-the-hypophar
UpToDate, Wolters Kluwer Health - 2012-04-24
Press Mentions
Radiation Therapy for Oligometastatic Renal Cell Carcinoma PromisingNovember 9th, 2021- April Salama’s War on Metastatic MelanomaJune 22nd, 2021
Committees
- Panel Vice-chair, Committee on Appropriateness Criteria, Expert Panel on Radiation Oncology - Head & Neck Cancer, American College of Radiology 2015 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
